Tongue discoloration in an elderly kidney transplant recipient: Treatment-related adverse event?

American Journal Geriatric Pharmacotherapy

Volumn 4, Issue 3, 2006, Pages 260-263

  Amir, Khalil A ^a,b   Bobba, Ravi K ^b   Clarke, Bridger ^c   Nagy Agren, Stephanie ^b   Arsura, Edward L ^b,d   Balogun, Seki A ^a   Evans, Jonathan M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d ST VINCENT S HOSPITAL   (United States)

Author keywords

elderly; immune compromised; linezolid; tongue discoloration

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; LINEZOLID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PREDNISOLONE; TSUKUBAENOLIDE; VALGANCICLOVIR;

AGED; ANAMNESIS; ARTHRALGIA; ARTICLE; CASE REPORT; CHILL; DRUG WITHDRAWAL; EMERGENCY WARD; ENTEROCOCCAL INFECTION; FATIGUE; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MALE; PANCYTOPENIA; PRIORITY JOURNAL; SCORING SYSTEM; TONGUE DISCOLORATION; TONGUE DISEASE; UNITED STATES; URINARY FREQUENCY; URINARY TRACT INFECTION;

ACETAMIDES; AGED; ANTI-INFECTIVE AGENTS; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; MALE; OXAZOLIDINONES; TONGUE DISEASES; URINARY TRACT INFECTIONS;

EID: 33750087558     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2006.09.001     Document Type: Article

References (16)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 32 (2004) 470-485
2. Scheinfeld N. Infections in the elderly. Dermatol Online J. 11 (2005) 8
3. Jones M.E., Karlowsky J.A., Draghi D.C., et al. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: A guide to appropriate antimicrobial therapy. Int J Antimicrob Agents 22 (2003) 406-419
4. Weigelt J., Itani K., Stevens D., et al., Linezolid CSSTI Study Group. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antirnicrob Agents Chemother. 49 (2005) 2260-2266
5. Lee E., Burger S., Shah J., et al. Linezolid-associated toxic optic neuropathy: A report of 2 cases. Clin Infect Dis. 37 (2003) 1389-1391
6. Bishop E., Melvani S., Howden B., et al. Good clinical outcomes but high rates of adverse reactions during finezolid therapy for serious infections: A proposed protocol for monitoring therapy in complex patients. Antimicrob Agents Chemother. 50 (2006) 1599-1602
7. Kopterides P., Papadomichelakis E., and Armaganidis A. Linezolid use associated with lactic acidosis. Scand J Infect Dis. 37 (2005) 153-154
8. Smith P.F., Birmingham M.C., Noskin G.A., et al. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant gram-positive infections in cancer patients with neutropenia. Ann Oncol. 14 (2003) 795-801
9. Matson K.L., and Miller S.E. Tooth discoloration after treatment with finezofid. Pharmacotherapy 23 (2003) 682-685
10. Zyvox (linezofid) [package insert] (2002), Pharmacia & Upjohn, Kalamazoo, Mich
11. Dresser L.D., and Rybak M.J. The pharmacologic and bacteriologic properties of oxazofidinones, a new class of synthetic antimicrobials. Pharmacotberapy 18 (1998) 456-462
12. Newman C.C., and Wagner R.F. Images in clinical medicine. Black hairy tongue. N Engl J Med. 337 (1997) 897
13. Sarti G.M., Haddy R.I., Schaffer D., and Kihm J. Black hairy tongue. Am Fam Physician 41 (1990) 1751-1755
14. Manabe M., Lim H.W., Winzer M., and Loomis C.A. Architectural organization of filiform papillae in normal and black hairy tongue epithelium: Dissection of differentiation pathways in a complex human epithelium according to their patterns of keratin expression. Arch Dermatol. 135 (1999) 177-181
15. Langtry J.A., Carr M.M., Steele M.C., and Ive P.A. Topical tretinoin: A new treatment for black hairy tongue (lingua rillosa nigra). Clin Exp Dermatol. 17 (1992) 163-164
16. Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 30 (1981) 239-245